19.30
-0.10
(-0.52%)
At close: January 10 at 8:07:45 AM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 4 | 4 |
Avg. Estimate | 61.52M | 62.23M | 234.45M | 260.73M |
Low Estimate | 60.2M | 61.5M | 232.5M | 256M |
High Estimate | 62.5M | 63.6M | 236M | 265.7M |
Year Ago Sales | 59.82M | 58.39M | 255.45M | 234.45M |
Sales Growth (year/est) | 2.85% | 6.57% | -8.22% | 11.21% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
HF7N.F | -- | -- | -- | -- |
S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Upgrades & Downgrades
Downgrade | Keefe, Bruyette & Woods: Outperform to Market Perform | 12/4/2024 |
Upgrade | Janney Montgomery Scott: Neutral to Buy | 11/15/2024 |
Upgrade | Piper Sandler: Neutral to Overweight | 10/24/2024 |
Maintains | DA Davidson: Neutral to Neutral | 10/23/2024 |
Reiterates | Wedbush: Neutral to Neutral | 10/23/2024 |
Reiterates | Jones Trading: Hold | 10/23/2024 |